X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Piramal Healthcare with Wockhardt - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PIRAMAL ENTERPRISES vs WOCKHARDT LTD. - Comparison Results

PIRAMAL ENTERPRISES    Change

Piramal Enterprises has a presence in custom manufacturing, critical care OTC and financial services. To give a boost to its custom manufacturing operations, the company had acquired Avecia Pharmaceuticals, UK in 2005 and Pfizer's Morpeth facility in... More

WOCKHARDT LTD. 
   Change

Wockhardt is one of the leading domestic pharmaceutical companies with strong presence in the lifestyle segment and a growing focus on biotechnology. While the company made a string of acquisitions in the past namely 'Esparma GmbH' in Germany, 'Pinew... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PIRAMAL ENTERPRISES WOCKHARDT LTD. PIRAMAL ENTERPRISES/
WOCKHARDT LTD.
 
P/E (TTM) x 7.5 -17.4 - View Chart
P/BV x 1.3 1.8 72.3% View Chart
Dividend Yield % 1.2 0.0 58,459.7%  

Financials

 PIRAMAL ENTERPRISES   WOCKHARDT LTD.
EQUITY SHARE DATA
    PIRAMAL ENTERPRISES
Mar-18
WOCKHARDT LTD.
Mar-18
PIRAMAL ENTERPRISES/
WOCKHARDT LTD.
5-Yr Chart
Click to enlarge
High Rs3,0831,012 304.7%   
Low Rs1,902532 357.9%   
Sales per share (Unadj.) Rs589.7355.9 165.7%  
Earnings per share (Unadj.) Rs284.0-60.3 -471.2%  
Cash flow per share (Unadj.) Rs310.5-46.8 -664.0%  
Dividends per share (Unadj.) Rs25.000.01 250,000.0%  
Dividend yield (eoy) %1.00 77,405.7%  
Book value per share (Unadj.) Rs1,467.0257.8 569.0%  
Shares outstanding (eoy) m180.27110.63 162.9%   
Bonus/Rights/Conversions IS--  
Price / Sales ratio x4.22.2 194.9%   
Avg P/E ratio x8.8-12.8 -68.5%  
P/CF ratio (eoy) x8.0-16.5 -48.6%  
Price / Book Value ratio x1.73.0 56.8%  
Dividend payout %8.80 -53,054.8%   
Avg Mkt Cap Rs m449,33285,379 526.3%   
No. of employees `0006.86.3 109.4%   
Total wages/salary Rs m19,8819,371 212.2%   
Avg. sales/employee Rs Th15,535.66,295.0 246.8%   
Avg. wages/employee Rs Th2,905.41,498.3 193.9%   
Avg. net profit/employee Rs Th7,482.5-1,066.3 -701.7%   
INCOME DATA
Net Sales Rs m106,31039,369 270.0%  
Other income Rs m2,5951,202 215.9%   
Total revenues Rs m108,90640,571 268.4%   
Gross profit Rs m51,59918 281,960.1%  
Depreciation Rs m4,7731,495 319.2%   
Interest Rs m29,7832,555 1,165.7%   
Profit before tax Rs m19,638-2,830 -694.0%   
Minority Interest Rs m2,8010-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-3,582 0.0%   
Tax Rs m-28,764257 -11,192.3%   
Profit after tax Rs m51,203-6,669 -767.8%  
Gross profit margin %48.50 104,415.9%  
Effective tax rate %-146.5-9.1 1,612.7%   
Net profit margin %48.2-16.9 -284.3%  
BALANCE SHEET DATA
Current assets Rs m118,15433,796 349.6%   
Current liabilities Rs m462,26026,917 1,717.3%   
Net working cap to sales %-323.717.5 -1,852.5%  
Current ratio x0.31.3 20.4%  
Inventory Days Days2779 33.5%  
Debtors Days Days4789 52.2%  
Net fixed assets Rs m113,72739,664 286.7%   
Share capital Rs m361553 65.2%   
"Free" reserves Rs m264,09327,968 944.3%   
Net worth Rs m264,45428,522 927.2%   
Long term debt Rs m242,20621,731 1,114.6%   
Total assets Rs m726,83481,620 890.5%  
Interest coverage x1.7-0.1 -1,543.3%   
Debt to equity ratio x0.90.8 120.2%  
Sales to assets ratio x0.10.5 30.3%   
Return on assets %11.1-5.0 -221.1%  
Return on equity %19.4-23.4 -82.8%  
Return on capital %10.3-7.7 -134.3%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m15,1109,807 154.1%   
Fx outflow Rs m4,2981,789 240.3%   
Net fx Rs m10,8138,019 134.8%   
CASH FLOW
From Operations Rs m-159,666684 -23,329.3%  
From Investments Rs m-17,6776,302 -280.5%  
From Financial Activity Rs m186,503-7,695 -2,423.8%  
Net Cashflow Rs m9,364-664 -1,410.3%  

Share Holding

Indian Promoters % 52.9 74.5 71.0%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 4.0 2.3 173.9%  
FIIs % 26.6 7.7 345.5%  
ADR/GDR % 0.0 0.1 -  
Free float % 16.5 15.4 107.1%  
Shareholders   93,274 67,757 137.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PIRAMAL ENTERPRISES With:   STRIDES PHARMA SCIENCE  AJANTA PHARMA  ALEMBIC LTD  DR. DATSONS LABS  ELDER PHARMA  

Compare PIRAMAL ENTERPRISES With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Tanks ahead of Election Results; Realty Stocks Plummet(Closing)

Indian share markets settled around 2% lower today following a sell-off in the global markets and due to uncertainty over the outcome of state assembly elections tomorrow.

Related Views on News

WOCKHARDT LTD. Announces Quarterly Results (2QFY19); Net Profit Down 158.2% (Quarterly Result Update)

Nov 12, 2018 | Updated on Nov 12, 2018

For the quarter ended September 2018, WOCKHARDT LTD. has posted a net profit of Rs 228 m (down 158.2% YoY). Sales on the other hand came in at Rs 11 bn (up 10.1% YoY). Read on for a complete analysis of WOCKHARDT LTD.'s quarterly results.

PIRAMAL ENTERPRISES Announces Quarterly Results (2QFY19); Net Profit Up 59.3% (Quarterly Result Update)

Nov 9, 2018 | Updated on Nov 9, 2018

For the quarter ended September 2018, PIRAMAL ENTERPRISES has posted a net profit of Rs 5 bn (up 59.3% YoY). Sales on the other hand came in at Rs 31 bn (up 24.0% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

My Top 7 Stocks to Buy Now(The 5 Minute Wrapup)

Nov 30, 2018

Of all the stocks that you could buy in this market, I've picked the seven best safe stocks that offer the ideal combination of safety and profit.

4 Rebound Stocks to Profit from the Current Small Cap Crash(Profit Hunter)

Dec 3, 2018

Indian small cap space is offering a discount season. Make sure you do not get too late to scoop up the bargains.

Reliance CPSE ETF (FFO3): Should You Invest?(Outside View)

Nov 29, 2018

Personalfn's analysis note on Reliance Mutual Fund Central Public Sector Enterprises Exchange Traded Fund (CPSE ETF). Should you subscribe?

Safety Beats Growth in 2018(Chart Of The Day)

Nov 30, 2018

With the markets turning up, these are my top 7 stock picks.

Looking For Higher Interest Rates on Bank FDs? Read This!(Outside View)

Dec 5, 2018

Credit disbursement to the productive sectors of the economy such as infrastructure, engineering, food processing, textiles, and chemicals, among others is rising.

More

Small Investments
BIG Returns

Zero To Millions Guide 2019
Get our special report, Zero To Millions
(2019 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

PIRAMAL ENTERPRISES SHARE PRICE


Dec 10, 2018 03:35 PM

TRACK PIRAMAL ENTERPRISES

  • Track your investment in PIRAMAL ENTERPRISES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PIRAMAL ENTERPRISES

PIRAMAL ENTERPRISES 5-YR ANALYSIS

COMPARE PIRAMAL ENTERPRISES WITH

MARKET STATS